FundedIQ
Biotechnology

Rejuvenation Technologies: Funding, Investors & Team (Oct 2026)

Rejuvenation Technologies is a biotech firm based in Mountain View, California that has successfully created nucleoside-modified TERT mRNA, a solution designed to efficiently and securely elongate telomeres.

www.rejuvenationtech.com LinkedIn Mountain View, United States 11-50 employees
Total raised
$10.6M
Rounds
1
Latest
Seed
Sep 2023

Rejuvenation Technologies has raised $10.6M across 1 funding round on record, the most recent a Seed of $10.6M announced in Sep 2023.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Rejuvenation Technologies Company Profile and Key Stats

Total funding raised
$10.6M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$10.6M in Sep 2023
Employees
11-50
reported band
Headquarters
Mountain View, United States

Latest funding round on record: Sep 2023.

Rejuvenation Technologies Funding Rounds

Date
Round
Amount
Seed
$10.6M

Rejuvenation Technologies Founders and Leadership Team

Name
Role
Contact
Glenn Markov
Founder
Locked

Contact details for the Rejuvenation Technologies team: 1 of 1 has an email address on file.

Start 14-day free trial →

Rejuvenation Technologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
17,054
$3.1M

Rejuvenation Technologies' latest round of $10.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Rejuvenation Technologies in Biotechnology and Mountain View

Companies Similar to Rejuvenation Technologies

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Rejuvenation Technologies Funding FAQs

What does Rejuvenation Technologies do?

Rejuvenation Technologies is a biotech firm based in Mountain View, California that has successfully created nucleoside-modified TERT mRNA, a solution designed to efficiently and securely elongate telomeres.

How much funding has Rejuvenation Technologies raised?

Rejuvenation Technologies has raised $10.6M across 1 round on record. The most recent is a Seed of $10.6M announced in Sep 2023.

When did Rejuvenation Technologies last raise funding?

Rejuvenation Technologies' most recent funding round on record is a Seed of $10.6M, announced in Sep 2023.

Who founded Rejuvenation Technologies?

FundedIQ lists Glenn Markov (Founder) at Rejuvenation Technologies.

Where is Rejuvenation Technologies headquartered?

Rejuvenation Technologies is based in Mountain View, California, United States.

How many employees does Rejuvenation Technologies have?

Rejuvenation Technologies is in the 11-50 employee band.

How does Rejuvenation Technologies' funding compare to other Biotechnology startups?

Rejuvenation Technologies' latest round of $10.6M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Rejuvenation Technologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rejuvenation Technologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.